30 results on '"Tang, W.H. Wilson"'
Search Results
2. Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
3. Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease From the PVDOMICS Study
4. The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline
5. Obesity and Weight Loss Strategies for Patients With Heart Failure
6. Clinical Outcomes of Metabolic Surgery on Diuretic Use in Patients With Heart Failure
7. Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases
8. Racial Differences in Diabetic Cardiomyopathy: The ARISE-HF Trial
9. Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
10. Race, Genotype, and Prognosis in Black Patients With Transthyretin Cardiac Amyloidosis
11. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
12. Meta-Analysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart Failure
13. Prognostic Value of Hemodynamic Gain Index in Patients With Heart Failure With Reduced Ejection Fraction
14. Cardiac MRI-Enriched Phenomapping Classification and Differential Treatment Outcomes in Patients With Ischemic Cardiomyopathy
15. Hemodynamic Determinants of Cardiac Surgery-Associated Acute Kidney Injury
16. Rationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) Study
17. 30- and 60-Day Readmission Rates for Children With Heart Failure in the United States
18. Pulmonary hypertension across the spectrum of left heart and lung disease
19. Hemodynamic Response after Intra-aortic Balloon Counter-Pulsation in Cardiac Amyloidosis and Cardiogenic Shock.
20. Comprehensive Clinical and Genetic Analyses of Circulating Bile Acids and Their Associations With Diabetes and Its Indices.
21. Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2is) Following FDA Approval for Heart Failure With Preserved and Mildly Reduced Ejection Fraction
22. Renal perturbations with sodium–glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction
23. Detection of Circulating Transthyretin Amyloid Aggregates in Plasma: A Novel Biomarker for Transthyretin Amyloidosis.
24. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM‐HF.
25. Blood Cholesterol and Triglycerides Associate with Right Ventricular Function in Pulmonary Hypertension
26. Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling
27. Formalized Frailty Evaluation Improves Provider Communication And Confidence In Frailty Assessment Of Patients With Advanced Heart Failure
28. Prognostic value of gut microbe‐generated metabolite phenylacetylglutamine in patients with heart failure.
29. Non‐invasive prediction of pulmonary vascular disease‐related exercise intolerance and survival in non‐group 1 pulmonary hypertension.
30. TCT-254 Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Patients With Stable Ischemic Cardiomyopathy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.